⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SeqOne Genomics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SeqOne Genomics
↗Montpellier, France
SeqOne Genomics is a French deep-tech company that provides an AI-powered, cloud-based genomic analysis platform designed to streamline clinical diagnostics. The platform enables molecular laboratories to process raw sequencing data into actionable clinical reports for oncology, rare diseases, and infectious diseases, significantly reducing turnaround times and costs.
The company has established itself as a global player in clinical genomics, particularly following its 2025 acquisition of the UK-based genomics firm Congenica. SeqOne serves over 160 laboratories across more than 30 countries, supporting the transition toward personalized medicine by making high-grade genomic interpretation accessible and scalable for healthcare providers.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Genomic Analysis / Bioinformatics
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$48.8M
Investors:Supernova Invest, Elaia, Omnes, Mérieux Equity Partners, IRDI Capital Investissement, Software Club
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Congenica, Life & Soft
Key Partnerships:Uppsala University Hospital (Clinical diagnostics), Cerba Internacional (NGS analysis), Genekor Medical (Oncology testing)
COMPETITION
Position:Emerging
Competitors:Strand Life Sciences, Helix, Hyrax Biosciences
LEADERSHIP
Key Executives:
Martin Dubuc - CEO
Nicolas Philippe - Chief Scientific Officer
Danaë Geraud - CFO
Scientific Founders:Nicolas Philippe, Guillaume Buwalda
LINKS
Website:seqone.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SeqOne Genomics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.